Risk assessment [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2014-09-24 05:34 (3875 d 17:44 ago) – Posting: # 13561
Views: 14,604

Hi Ohlbe,

❝ That's all very fine for efficacy. But what about safety ?


That’s not really covered in the paper since the authors explored only bioinequivalence at the lower end (T/R 70%) of 400 mg. However, higher IR strengths of 600, 650, and 800 mg (CR 1,000 mg) are on the European market; note that 400/0.7 < 600. Above 400 mg the PK is less than dose proportional. The maximum daily dose is 2,400 mg. In the Biowaiver Monograph the risk was assessed as being low.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,667 registered users;
50 visitors (0 registered, 50 guests [including 5 identified bots]).
Forum time: 23:18 CEST (Europe/Vienna)

Patients may recover in spite of drugs or because of them.    John Gaddum

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5